Literature DB >> 24985351

[Cost of a renal transplant: medico-economic analysis of the amount reimbursed by the French national health program to finance renal transplantation].

Yoël Sainsaulieu1, Cléa Sambuc2, Hélène Logerot1, Isabelle Bongiovanni2, Cécile Couchoud3.   

Abstract

Successful organ transplantation relies on several ancillary activities such as the identification of a compatible donor, organ allocation and procurement and the coordination of the transplant process. No existing study of the overall costs, in France, of these additional transplantation activities could be identified. This study determines the total additional costs of ancillary transplantation activities by comparing the costs of kidney transplantations with living donors against those using deceased donors. The data used are drawn from the 2013 public healthcare tariff calculations, PMSI recorded activity and transplant activity in 2012 as assessed and reported by the Agence de la biomédecine. The results show that, in 2012, additional transplant costs varied from 13835.44 € to 20050.67 € for a deceased donor and were 13601.66 € for a living donor. In conclusion, this study demonstrates that all the costs covered by National Health Insurance need to be taken into account in the economic impact evaluation of renal transplantation and during the development of this national priority activity.
Copyright © 2014 Association Société de néphrologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Assurance maladie; Donneur vivant; Financement; Funding; Graft; Greffon; Health insurance; Living donor; Renal transplantation; Transplantation rénale

Mesh:

Year:  2014        PMID: 24985351     DOI: 10.1016/j.nephro.2014.01.009

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  2 in total

1.  Global Perspective on Kidney Transplantation: France.

Authors:  Gillian Divard; Valentin Goutaudier
Journal:  Kidney360       Date:  2021-08-06

2.  A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events.

Authors:  Anne-Line Couillerot-Peyrondet; Cléa Sambuc; Yoël Sainsaulieu; Cécile Couchoud; Isabelle Bongiovanni-Delarozière
Journal:  Eur J Health Econ       Date:  2016-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.